Medrol and Epididymitis - a phase IV clinical study of FDA data

Summary:

Epididymitis is reported as a side effect among people who take Medrol (methylprednisolone), especially for people who are 50-59 old, also take Lasix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Epididymitis when taking Medrol. It is created by eHealthMe based on reports of 23,951 people who have side effects when taking Medrol from the FDA, and is updated regularly.

What is Medrol?

Medrol has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 24,443 Medrol users. Check the latest studies of Medrol.

What is Epididymitis?

Epididymitis (pain in the scrotum or testicle) is found to be associated with 257 drugs and 399 conditions by eHealthMe. Check the latest studies of Epididymitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

23,951 people reported to have side effects when taking Medrol.
Among them, 27 people (0.11%) have Epididymitis.

Among these 27 people:

What is the age of people who have Epididymitis when taking Medrol? *

What are other drugs people take besides Medrol? *

What are other side effects people have besides Epididymitis? *

Infection: 21 people, 77.78%
Hydrocele: 20 people, 74.07%
Fever: 19 people, 70.37%
Atherosclerosis (disorder of the arteries): 19 people, 70.37%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 19 people, 70.37%
Wheezing (a high-pitched whistling sound made while you breath): 18 people, 66.67%
Muscle Twitching: 18 people, 66.67%
Leukocytosis (increased white blood cells): 18 people, 66.67%
International Normalised Ratio Increased: 18 people, 66.67%
Insomnia (sleeplessness): 18 people, 66.67%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 18 people, 66.67%
Pyogenic Liver Abscess (liver abscess caused by bacteria): 1 person, 3.70%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 3.70%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Medrol and have Epididymitis?

- Check whether Epididymitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Medrol:

Medrol (24,443 reports)

Epididymitis treatments and more:

Epididymitis (2,459 reports)

Browse all side effects of Medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epididymitis:

Epididymitis (257 drugs)

Browse all the conditions that are associated with Epididymitis:

Epididymitis (399 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone (the active ingredients of Medrol) and Medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.